1> Cytokinetics set to make commercial impact, says Piper Sandler 20:24 CYTK Piper Sandler transferred coverage of Cytokinetics to analyst Yasmeen Rahimi, who maintained an Overweight rating and raised the price target to $50 from $40. The company's Omecamtiv has met primary endpoint in a Phase 3 trial in heart failure with reduced ejection fraction with NDA filing in the second half of 2021, while aficamten has shown robust efficacy in hypertrophic cardiomyopathies, which is inline with the Phase 3 completed mavacamten data, the analyst tells investors in a research note. Rahimi further states that with three derisked late stage clinical assets, Cytokinetics is all set to make a commercial impact. 2> Cytokinetics to hold analyst and investor day 17:19 CYTK Analyst & Investor Day 2021 to be held in New York on October 7 at 8:30 am. Webcast Link 3>
This is the third in my series of GBA shorts voice over commercials -- The Market is a place full of twists and turns. Get on board with GBA and do this-
#4) It's not easy. We all know that. It takes teamwork, guts and a strong stroke. gummybear advisors keeps you ahead of that wave.
Wait-This is getting weird- goldbely.com A Yummy Item Has Shipped!-What! WOOOOHOOOO! An order from Pappy's Smokehouse is on its way to your door! SHIPMENT DETAILS Pappy's World Famous Ribs - 4 Racks from Pappy's Smokehouse
Well she was nice as could be and I did not make it easy. She's a journalism major and she's going the baseball game tonight. Her grandpa has had tickets forever<-- Busted! He's a red sox fan I said- Silence. I know someone was next to her saying move on move on don't answer-- Grandpa's a Red Sox fan. I said again. Again silence.... I learned I am class of 87' a very cool year. I'm proud of that. She took my CC number and asked hows' my day been, I said Well, I Was $800 richer a minute ago but OK...